Inventor · disambiguated record
Tracy J. Jenkins
Also filed as: JENKINS TRACY · JENKINS TRACY J
21 granted patents·9 pending applications·310 citations·filing 1999–2024
95Inventor score
Files withBIOGEN MA INC9SUNESIS PHARMACEUTICALS INC4VIRACTA THERAPEUTICS INC4BIOGEN IDEC INC3MILLENNIUM PHARM INC3
Top patents by PatentIndex Score
30 records- 0194US6187777B1Compounds and methods which modulate feeding behavior and related diseasesAMGEN INC·Filed 1999·Granted Feb 13, 2001·134 cites·20 claims
- 0293US6583154B1Compounds and methods which modulate feeding behavior and related diseasesAMGEN INC·Filed 2000·Granted Jun 24, 2003·57 cites·16 claims
- 0392US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0491US9944622B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·8 cites·16 claims
- 0591US9353087B2Inhibitors of Bruton's tyrosine kinaseBIOGEN IDEC INC·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 0691US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0789US9394277B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2013·Granted Jul 19, 2016·11 cites·26 claims
- 0889US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 0984US10618887B2Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·3 cites·17 claims
- 1084US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 1184US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1283US9273028B2Heterocyclic tyrosine kinase inhibitorsHOPKINS BRIAN T·Filed 2011·Granted Mar 1, 2016·6 cites·8 claims
- 1383US2024417389A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1482US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 1582US10246456B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2015·Granted Apr 2, 2019·5 cites·4 claims
- 1678US9617282B2Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseasesBIOGEN MA INC·Filed 2014·Granted Apr 11, 2017·3 cites·13 claims
- 1778US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1877US2023174511A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1975US7329755B2CCR8 inhibitorsMILLENNIUM PHARM INC·Filed 2003·Granted Feb 12, 2008·11 cites·9 claims
- 2073US10577367B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2019·Granted Mar 3, 2020·1 cites·6 claims
- 2172US7491827B2Aryl sulfonamides useful as inhibitors of chemokine receptor activityMILLENNIUM PHARM INC·Filed 2004·Granted Feb 17, 2009·5 cites·32 claims
- 2270US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2368US2021017155A1Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2467US7378525B2CCR8 inhibitorsMILLENNIUM PHARM INC·Filed 2003·Granted May 27, 2008·4 cites·9 claims
- 2563US10189817B2Inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·0 cites·6 claims
- 2656US8063222B2Aryl sulfonamides useful as inhibitors of chemokine receptor activityDAI MINGSHI·Filed 2008·Granted Nov 22, 2011·0 cites·20 claims
- 2754US2017114039A1Inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2850US2017027956A1Heterocyclic tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2942US11427561B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2017·Granted Aug 30, 2022·0 cites·20 claims
- 3041US2005143372A1Compounds, pharmaceutical compositions and methods of use thereforFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →